Literature DB >> 8272403

Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action.

C Ropert1, C Malvy, P Couvreur.   

Abstract

Proliferation of the Friend retrovirus was specifically inhibited by the env mRNA complementary oligonucleotide encapsulated in pH-sensitive liposomes. This observation was made using the focus immunoassay (FIA) and the reverse transcriptase test. The key finding of the present study was the dramatic impact on liposome penetration. For chronic or de novo infection, the point at which the penetration of liposomes began corresponded to the time needed for the virus to leave the cell. In the absence of the virus, liposomes remained adsorbed onto the cell surface without any internalization. Regardless of the mechanism involved, the fact that a retroviral infection stimulates the cellular uptake of oligonucleotide liposomes widens the spectrum of strategies for specific antiviral action.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8272403     DOI: 10.1023/a:1018910922633

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Intracellular distribution of microinjected antisense oligonucleotides.

Authors:  J P Leonetti; N Mechti; G Degols; C Gagnor; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 2.  Nucleoside phosphorothioates.

Authors:  F Eckstein
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.

Authors:  B Chesebro; K Wehrly; M Cloyd; W Britt; J Portis; J Collins; J Nishio
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

4.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.

Authors:  M L Stephenson; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

6.  Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses.

Authors:  M Sitbon; J Nishio; K Wehrly; D Lodmell; B Chesebro
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

7.  Nonionic nucleic acid analogues. Synthesis and characterization of dideoxyribonucleoside methylphosphonates.

Authors:  P S Miller; J Yano; E Yano; C Carroll; K Jayaraman; P O Ts'o
Journal:  Biochemistry       Date:  1979-11-13       Impact factor: 3.162

8.  Syncytia formation in HIV-1 infected cells is associated with an increase in cellular oleic acid.

Authors:  K Apostolov; W Barker; S A Galpin; N A Habib; C B Wood; D Kinchington
Journal:  FEBS Lett       Date:  1989-07-03       Impact factor: 4.124

9.  Oligodeoxynucleotide stability in subcellular extracts and culture media.

Authors:  E Wickstrom
Journal:  J Biochem Biophys Methods       Date:  1986-09

10.  Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides.

Authors:  C Chavany; T Le Doan; P Couvreur; F Puisieux; C Hélène
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

View more
  9 in total

Review 1.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

2.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 3.  Application of antisense DNA method for the study of molecular bases of brain function and behavior.

Authors:  S Ogawa; D W Pfaff
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

4.  Preparation of functional liposomes with peptide ligands and their binding to cell membranes.

Authors:  N Yagi; Y Ogawa; M Kodaka; T Okada; T Tomohiro; T Konakahara; H Okuno
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

5.  Synthesis of a novel lipopeptide with alpha-melanocyte-stimulating hormone peptide ligand and its effect on liposome stability.

Authors:  Y Ogawa; H Kawahara; N Yagi; M Kodaka; T Tomohiro; T Okada; T Konakahara; H Okuno
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

6.  Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly(isobutylcyanoacrylate) nanoparticles after intravenous administration in mice.

Authors:  Y Nakada; E Fattal; M Foulquier; P Couvreur
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

7.  Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides.

Authors:  A Bochot; E Fattal; A Gulik; G Couarraze; P Couvreur
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

8.  Lysine: Is it worth more?

Authors:  D Datta; A Bhinge; V Chandran
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

Review 9.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.